نتائج البحث

Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.

• Authors : Gervasini, Guillermo¹ ; Garcíí-Martín, Elena² ; Ladero, José M.³

• Source: BMC Cancer. 2007, Vol. 7, p1-7. 7p.

تفاصيل العنوان

Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.

• Authors : Bethke, Lara¹ ; Webb, Emily¹ ; Sellick, Gabrielle¹

• Source: BMC Cancer. 2007, Vol. 7, p1-7. 7p.

تفاصيل العنوان

Effect of isavuconazole on the pharmacokinetics of sunitinib and its mechanism

• Authors : Jinyu Hu; Hailun Xia; Xiaohai Chen

Subjects: TKI; Sunitinib; Isavuconazole

• Source: BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)

تفاصيل العنوان

Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study

• Authors : Min Kyoung Kim; Jeong Yee; Yoon Sook Cho

Subjects: Erlotinib; Hepatotoxicity; CYP3A4 inducers

• Source: BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)

تفاصيل العنوان

Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells.

• Authors : Habano, Wataru¹ ; Gamo, Toshie¹; Terashima, Jun¹

• Source: BMC Cancer. 2011, Vol. 11 Issue 1, p81-90. 10p.

تفاصيل العنوان

Genome-wide gene copy number and expressionanalysis of primary gastric tumors and gastriccancer cell lines.

• Authors : Junnila, Siina¹; Kokkola, Arto²; Karjalainen-Lindsberg, Marja-Liisa³

• Source: BMC Cancer. 2010, Vol. 10, p73-83. 11p.

تفاصيل العنوان

Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.

• Authors : Li MM; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.; State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*pathology ; Gene Expression Profiling/Gene Expression Profiling/Gene Expression Profiling/*methods

• Source: BMC cancer [BMC Cancer] 2019 Aug 28; Vol. 19 (1), pp. 851. Date of Electronic Publication: 2019 Aug 28.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNFα biologic for ulcerative colitis: a case report.

• Authors : Henderson SL; Division of Clinical Pharmacology, Department of Medicine, 339 Windermere Road B9-130, London, ON, N6A 5A5, Canada.; Pharmacy Services London Health Sciences Centre, Western University, London, ON, Canada.

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Colitis, Ulcerative/Colitis, Ulcerative/Colitis, Ulcerative/*drug therapy ; Rifampin/Rifampin/Rifampin/*therapeutic use

• Source: BMC cancer [BMC Cancer] 2016 May 11; Vol. 16, pp. 304. Date of Electronic Publication: 2016 May 11.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان